Regulation of IL-17 has recently been proposed as an attractive therapeutic approach for asthma [50], a common inflammatory respiratory condition involving eosinophilic and neutrophilic infiltrates that often co-exists in CF patients. This evidence concerns the gene IL17A and asthma.